How to Revive Breakthrough Innovation in the Pharmaceutical Industry-Reference-Cited by-同舟云学术

How to Revive Breakthrough Innovation in the Pharmaceutical Industry

Published:2011-06-29 Issue:89 Volume:3 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Munos Bernard H.¹,Chin William W.²

Affiliation:

1. InnoThink Center for Research in Biomedical Innovation, Indianapolis, IN 46228–1422, USA.

2. Harvard Medical School, Boston, MA 02115–6027, USA.

Abstract

Pharmaceutical firms must reengage in high-risk discovery research and only take genuine breakthroughs to the clinic.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference27 articles.

1. E. Arias United States Life Tables 2006. National Vital Statistics Report Volume 58 (28 June 2010). http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_21.pdf.

2. Data available at www.fda.gov/downloads/AboutFDA/Transparency/Basics/UCM247465.pdf.

3. Portfolio analysis and R&D decision making

4. F. M. Scherer Markets and Uncertainty in Pharmaceutical Development Working Paper RWP07-039 Harvard University September 2007. http://web.hks.harvard.edu/publications/getFile.aspx?Id=267.

5. Aranesp (darbepoetin alpha Amgen) Neulasta (pegfilgrastim Amgen) Zocor (simvastatin Merck & Co) Eloxatin (oxaliplatin Sanofi) PegIntron (peginterferon alpha-2b Merck & Co) Humalog (recombinant insulin lispro Eli Lilly) Augmentin (amoxicillin + clavulanate potassium GlaxoSmithKline).

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulating ethical experimentation: Impacts of the breakthrough therapy designation on drug R&D;Journal of Health Economics;2024-03

2. Spurred or spurned? The effects of combined innovations and major obstacles on B2B SME capability generation and future focus;Industrial Marketing Management;2023-08

3. International strategic alliances for collaborative product Innovation: An agent-based scenario analysis in biopharmaceutical industry;Journal of Business Research;2023-03

4. Bioethics and sociology: the place of social studies of science and technology;Interface - Comunicação, Saúde, Educação;2023

5. The Risk of Caution: Evidence from an Experiment;Management Science;2022-12